Rainbow Childrens Medicare schedules investor meetings for Sep 18-22

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Rainbow Childrens Medicare schedules investor meetings for Sep 18-22, 2026
  • Engagements include Kotak Healthcare Forum and J.P. Morgan Flagship Conference
  • All meetings are in-person group sessions held in Mumbai
  • No UPSI will be shared during these investor interactions
powered bylight_fuzz_icon
50674444

*this image is generated using AI for illustrative purposes only.

Rainbow Children's Medicare Limited Rainbow Children's Medicare has announced a schedule of in-person meetings with analysts and institutional investors for September 18 to 22, 2026.

The healthcare company will engage with stakeholders at three major financial forums in Mumbai during this period. These interactions are part of the firm's regular investor relations activities under SEBI Listing Regulations.

Meeting Schedule

The company confirmed that no Unpublished Price Sensitive Information (UPSI) will be shared during these engagements. The schedule is subject to change due to exigencies.

Date Event Mode Venue Type
September 18, 2026 Kotak Healthcare Forum 2026 In-Person Mumbai Group
September 21, 2026 Anand Rathi G-200 Summit 2026 In-Person Mumbai Group
September 22, 2026 J.P. Morgan Flagship India Conference In-Person Mumbai Group

Regulatory Disclosure

The intimation was issued pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shreya Mitra, Company Secretary and Compliance Officer, signed the disclosure on September 11, 2026.

The company's registered office is located in Hyderabad, Telangana.

Historical Stock Returns for Rainbow Childrens Medicare

1 Day5 Days1 Month6 Months1 Year5 Years
-0.12%-5.64%-5.02%+17.48%-0.90%+204.89%

How might Rainbow Children's Medicare's presentations at these high-profile forums influence institutional investor sentiment and stock valuation in the near term?

What specific growth metrics or expansion strategies is the company likely to highlight to justify its current market capitalization during these meetings?

Could the timing of these investor interactions signal an upcoming strategic announcement, such as new hospital acquisitions or partnerships, despite the UPSI restriction?

Rainbow Childrens Medicare
View Company Insights
View All News
like18
dislike

Rainbow Childrens Medicare accepts Srinath Metla resignation

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Rainbow Childrens Medicare accepted Srinath Metla's resignation as Chief Strategy and Growth Officer
  • The departure is due to personal reasons with a last working day of September 5, 2026
  • Disclosure was made under Regulation 30 of SEBI LODR Regulations and Schedule III
  • Mr. Metla holds the status of Senior Managerial Personnel under listing rules
powered bylight_fuzz_icon
49722440

*this image is generated using AI for illustrative purposes only.

Rainbow Childrens Medicare accepted the resignation of Chief Strategy and Growth Officer Srinath Metla on August 31, 2026. The executive cited personal reasons for stepping down.

Mr. Metla will be relieved from his duties at the close of business hours on September 5, 2026. This date marks his last working day with the company.

Regulatory Disclosure

The company made the disclosure pursuant to Regulation 30 of the SEBI LODR Regulations and Schedule III. It also referenced SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Mr. Metla is classified as Senior Managerial Personnel under the SEBI Listing Regulations. The management appreciated his contributions during his tenure.

Key Details

Particulars Details
Reason Personal reasons
Last Working Day September 5, 2026
Role Chief Strategy and Growth Officer

The resignation communication and disclosure annexures are available on the company website.

Historical Stock Returns for Rainbow Childrens Medicare

1 Day5 Days1 Month6 Months1 Year5 Years
-0.12%-5.64%-5.02%+17.48%-0.90%+204.89%

Has Rainbow Childrens Medicare announced a timeline or criteria for appointing a successor to the Chief Strategy and Growth Officer role?

How might the departure of a key senior managerial figure impact the company's strategic growth initiatives and market expansion plans for FY2027?

Are there any pending regulatory filings or internal investigations related to Mr. Metla's tenure that could influence investor sentiment?

Rainbow Childrens Medicare
View Company Insights
View All News
like15
dislike

More News on Rainbow Childrens Medicare

1 Year Returns:-0.90%